SCHEMBL4423382

SCHEMBL4423382

CCCCC1C(c2ccc(O)cc2)=C(c2ccccc2)c2cc(O)ccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
CYP3A4 P08684 2/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45
TP53 P04637 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
PTGS1 P23219 1/20 0.45
RAB9A P51151 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
ESR2 Q92731 13/20 0.41
ESR1 P03372 12/20 0.41
ABL1 P00519 1/20 0.36
ABCB1 P08183 1/20 0.36
BCR P11274 1/20 0.36
KCNA5 P22460 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27364151 0.74 ALDH1A1 (0.43) ALDH1A1CYP3A4LMNACYP1A2CYP2C9
SCHEMBL6056629 0.72 CYP3A4 (0.42) ALDH1A1CYP3A4LMNACYP1A2CYP2C9
SCHEMBL4415462 0.71 ESR2 (0.48) ESR2ESR1MMP3BCL2L1HSD17B1
SCHEMBL4420088 0.66 ESR2 (0.44) ALDH1A1MAPTHPGDESR2ESR1
Pentane SCHEMBL28008464 0.65 HSD17B1 (0.73) CYP3A4CYP1A2CYP2C9CYP2C19ESR2
Hydrochloric Acid SCHEMBL31313327 0.65 PTPN1 (0.37) ALDH1A1CYP3A4LMNACYP1A2CYP2C9
SCHEMBL313685 0.64 ACHE (0.55) CYP3A4LMNATP53KCNH2
Butane SCHEMBL2769411 0.64 MMP3 (0.75) LMNAMAPTHPGDRAB9AESR2
SCHEMBL13303151 0.64 DYRK1A (0.44) ALDH1A1CYP3A4LMNACYP1A2CYP2C9
Oxyphenbutazone Anhydrous SCHEMBL25856 0.62 LMNA (1.00) ALDH1A1CYP3A4LMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090326018-A1 2-Phenyl indene derivatives useful as estrogen receptor ligands KARO BIO AB (SE) 2009-12-31 US claimed
US-20090326018-A1 2-Phenyl indene derivatives useful as estrogen receptor ligands KARO BIO AB (SE) 2009-12-31 US disclosed
US-20090326018-A1 2-Phenyl indene derivatives useful as estrogen receptor ligands KARO BIO AB (SE) 2009-12-31 US disclosed
WO-2008043567-A1 2-PHENYL INDENE DERIVATIVES USEFUL AS ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2008-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326018-A1 2-Phenyl indene derivatives useful as estrogen receptor ligands ESR1, GPER1, ESR2 ALDH1A1 1020/4885CYP3A4 885/4885LMNA 2411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.